SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SB-2 - Optional form for registration of securities to be sold to the public by small business issuers:
SEC Accession No. 0001193125-06-008021
Filing Date
2006-01-18
Accepted
2006-01-18 17:20:34
Documents
10

Document Format Files

Seq Description Document Type Size
1 SB-2 FOR CARDIUM THERAPEUTICS, INC. dsb2.htm SB-2 1264486
2 AGREEMENT OF PLAN OF MERGER dex24.htm EX-2.4 24451
3 CERTIFICATE OF MERGER dex25.htm EX-2.5 7717
4 SECOND AMENDED AND RESTATED CERTIFICATE dex3i.htm EX-3.(I) 31136
5 AMENDED AND RESTATED BYLAWS dex3ii.htm EX-3.(II) 69153
6 OPINION OF FISHER THURBER LLP dex51.htm EX-5.1 8922
7 CONSENT OF MARCUM & KLIEGMAN LLP dex232.htm EX-23.2 2183
8 CONSENT OF MARCUM & KLIEGMAN LLP (ARIES). dex233.htm EX-23.3 2119
9 CONSENT OF WEINBERG & COMPANY, P.A. dex234.htm EX-23.4 2513
10 GRAPHIC g50525g36g89.jpg GRAPHIC 25912
  Complete submission text file 0001193125-06-008021.txt   1450205
Mailing Address 3611 VALLEY CENTRE DRIVE, SUITE 525 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE, SUITE 525 SAN DIEGO CA 92130 (858) 436-1000
Cardium Therapeutics, Inc. (Filer) CIK: 0000772320 (see all company filings)

IRS No.: 840635673 | Fiscal Year End: 1231
Type: SB-2 | Act: 33 | File No.: 333-131104 | Film No.: 06536260
SIC: 2836 Biological Products, (No Diagnostic Substances)